These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 39389720)

  • 1. Biologics in Asthma: Potential to Achieve Clinical Remission.
    Rivera O; Katial R; Hoyte FCL
    Immunol Allergy Clin North Am; 2024 Nov; 44(4):725-736. PubMed ID: 39389720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative efficacy of tezepelumab to mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: A Bayesian network meta-analysis.
    Nopsopon T; Lassiter G; Chen ML; Alexander GC; Keet C; Hong H; Akenroye A
    J Allergy Clin Immunol; 2023 Mar; 151(3):747-755. PubMed ID: 36538979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-World Studies of Biologics for the Treatment of Moderate-to-Severe Asthma.
    Desai M; Haines A; Oppenheimer JJ
    Immunol Allergy Clin North Am; 2024 Nov; 44(4):737-750. PubMed ID: 39389721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spanish Consensus on Remission in Asthma (REMAS).
    Álvarez-Gutiérrez FJ; Casas-Maldonado F; Soto-Campos G; Blanco-Aparicio M; Delgado J; Galo AP; Quirce S; Plaza V;
    Arch Bronconeumol; 2024 Aug; 60(8):503-509. PubMed ID: 38697903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smaller Differences in the Comparative Effectiveness of Biologics in Reducing Asthma-Related Hospitalizations Compared With Overall Exacerbations.
    Akenroye A; Marshall J; Simon AL; Hague C; Costa R; Jamal-Allial A; McMahill-Walraven CN; Haffenreffer K; Han A; Wu AC
    J Allergy Clin Immunol Pract; 2024 Jun; 12(6):1568-1574.e2. PubMed ID: 38431251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When sequential use of mepolizumab and dupilumab in a severe atopic eosinophilic asthmatic questions the role of eosinophils in mediating the clinical expression of the disease: a case report.
    Sabbe M; Schleich F; Janssens P; Louis R
    J Med Case Rep; 2024 Jan; 18(1):63. PubMed ID: 38291489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Biologics for Oral Corticosteroid-Dependent Asthma: A Systematic Review and Network Meta-Analysis.
    Phinyo P; Krikeerati T; Vichara-Anont I; Thongngarm T
    J Allergy Clin Immunol Pract; 2024 Feb; 12(2):409-420. PubMed ID: 37972921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tezepelumab compared with other biologics for the treatment of severe asthma: a systematic review and indirect treatment comparison.
    Menzies-Gow A; Steenkamp J; Singh S; Erhardt W; Rowell J; Rane P; Martin N; Ackert JL; Quinton A
    J Med Econ; 2022; 25(1):679-690. PubMed ID: 35570578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Relationship of Asthma Biologics to Remission for Asthma.
    Menzies-Gow A; Szefler SJ; Busse WW
    J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1090-1098. PubMed ID: 33130146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of complete responders versus non-complete responders to omalizumab, benralizumab and mepolizumab in patients with severe asthma: a long-term retrospective analysis.
    Basagaña M; Martínez-Rivera C; Padró C; Garcia-Olivé I; Martínez-Colls M; Navarro J; Pardo L; Cruz P; Cardona Peitx G; Carabias L; Roger A; Abad J; Rosell A
    Ann Med; 2024 Dec; 56(1):2317356. PubMed ID: 38364218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to Biologics and Clinical Remission in the Adult German Asthma Net Severe Asthma Registry Cohort.
    Milger K; Suhling H; Skowasch D; Holtdirk A; Kneidinger N; Behr J; Timmermann H; Schulz C; Schmidt O; Ehmann R; Hamelmann E; Idzko M; Taube C; Lommatzsch M; Buhl R; Korn S
    J Allergy Clin Immunol Pract; 2023 Sep; 11(9):2701-2712.e2. PubMed ID: 37301433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologics for severe asthma: The real-world evidence, effectiveness of switching, and prediction factors for the efficacy.
    Nagase H; Suzukawa M; Oishi K; Matsunaga K
    Allergol Int; 2023 Jan; 72(1):11-23. PubMed ID: 36543689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Biologics in Patients with Allergic Severe Asthma, Overall and by Blood Eosinophil Count: A Literature Review.
    Bernstein JA; Llanos JP; Hunter G; Martin N; Ambrose CS
    Adv Ther; 2023 Nov; 40(11):4721-4740. PubMed ID: 37698716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developments in the Management of Severe Asthma in Children and Adolescents: Focus on Dupilumab and Tezepelumab.
    van Dijk YE; Rutjes NW; Golebski K; Şahin H; Hashimoto S; Maitland-van der Zee AH; Vijverberg SJH
    Paediatr Drugs; 2023 Nov; 25(6):677-693. PubMed ID: 37658954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precision care in the treatment of pediatric asthma.
    Mahmood L; Keskin S; Jefferson AA
    Curr Opin Pediatr; 2024 Jun; 36(3):304-309. PubMed ID: 38411592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologics in Asthma: Emerging Biologics.
    Desai B; Adrish M; Mohan A; Lugogo NL
    Immunol Allergy Clin North Am; 2024 Nov; 44(4):751-763. PubMed ID: 39389722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New perspectives of childhood asthma treatment with biologics.
    Just J; Deschildre A; Lejeune S; Amat F
    Pediatr Allergy Immunol; 2019 Mar; 30(2):159-171. PubMed ID: 30444939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cost comparison of benralizumab, mepolizumab, and dupilumab in patients with severe asthma: A US third-party payer perspective.
    Xu X; Schaefer C; Szende A; Genofre E; Katial R; Chung Y
    J Manag Care Spec Pharm; 2023 Nov; 29(11):1193-1204. PubMed ID: 37796731
    [No Abstract]   [Full Text] [Related]  

  • 19. Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients.
    Thomas D; McDonald VM; Stevens S; Harvey ES; Baraket M; Bardin P; Bowden JJ; Bowler S; Chien J; Chung LP; Gillman A; Hew M; Hodge S; James A; Jenkins C; Katelaris CH; Katsoulotos GP; Langton D; Lee J; Marks G; Peters M; Radhakrishna N; Reynolds PN; Rimmer J; Sivakumaran P; Upham JW; Wark P; Yang IA; Gibson PG
    Allergy; 2024 Feb; 79(2):384-392. PubMed ID: 37632144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological treatments in childhood asthma.
    Nieto-García A; Nieto-Cid M; Mazón-Ramos Á
    Curr Opin Allergy Clin Immunol; 2024 Jun; 24(3):114-121. PubMed ID: 38567842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.